XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 11 2020
Historique:
received: 19 03 2020
accepted: 07 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 17 12 2020
Statut: epublish

Résumé

Recent studies demonstrated a dramatically increased risk of leukemia in patients with a rare genetic disorder, Xeroderma Pigmentosum group C (XP-C), characterized by constitutive deficiency of global genome nucleotide excision repair (GG-NER). The genetic mechanisms of non-skin cancers in XP-C patients remain unexplored. In this study, we analyze a unique collection of internal XP-C tumor genomes including 6 leukemias and 2 sarcomas. We observe a specific mutational pattern and an average of 25-fold increase of mutation rates in XP-C versus sporadic leukemia which we presume leads to its elevated incidence and early appearance. We describe a strong mutational asymmetry with respect to transcription and the direction of replication in XP-C tumors suggesting association of mutagenesis with bulky purine DNA lesions of probably endogenous origin. These findings suggest existence of a balance between formation and repair of bulky DNA lesions by GG-NER in human body cells which is disrupted in XP-C patients.

Identifiants

pubmed: 33203900
doi: 10.1038/s41467-020-19633-9
pii: 10.1038/s41467-020-19633-9
pmc: PMC7672101
doi:

Substances chimiques

DNA-Binding Proteins 0
XPC protein, human 156533-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5834

Références

J Mol Biol. 2001 Sep 14;312(2):335-46
pubmed: 11554790
Genome Res. 2016 Feb;26(2):174-82
pubmed: 26755635
Cell Rep. 2014 Nov 20;9(4):1228-34
pubmed: 25456125
Anaesth Intensive Care. 2014 May;42(3):310-4
pubmed: 24794469
Bioinformatics. 2012 Oct 1;28(19):2520-2
pubmed: 22908215
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Curr Protoc Bioinformatics. 2014 Sep 08;47:11.12.1-34
pubmed: 25199790
DNA Repair (Amst). 2011 Jun 10;10(6):577-85
pubmed: 21482201
Hum Gene Ther. 2003 Jul 1;14(10):983-96
pubmed: 12869216
BMC Bioinformatics. 2019 Sep 2;20(1):450
pubmed: 31477009
Nucleic Acids Res. 2016 Sep 19;44(16):e131
pubmed: 27270079
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
BMC Genomics. 2019 Aug 30;20(1):685
pubmed: 31470794
Arch Dermatol. 1987 Feb;123(2):241-50
pubmed: 3545087
Cell Cycle. 2011 Jul 15;10(14):2276-80
pubmed: 21701262
Bioinformatics. 2012 Jul 15;28(14):1919-20
pubmed: 22576172
Genome Res. 2007 Jun;17(6):917-27
pubmed: 17568007
Oncogene. 2005 Jan 13;24(3):469-78
pubmed: 15558025
Bioinformatics. 2018 Jan 15;34(2):330-337
pubmed: 29028923
Bioinformatics. 2008 Dec 1;24(23):2684-90
pubmed: 18852176
Cell Rep. 2013 Jan 31;3(1):246-59
pubmed: 23318258
Arch Dermatol. 1994 Aug;130(8):1018-21
pubmed: 8053698
Genet Med. 2018 Oct;20(10):1196-1205
pubmed: 29388947
Orphanet J Rare Dis. 2011 Nov 01;6:70
pubmed: 22044607
Genome Biol. 2018 Jul 24;19(1):95
pubmed: 30041675
Bioinformatics. 2018 Mar 1;34(5):867-868
pubmed: 29096012
Oncogene. 2000 Oct 12;19(43):5034-7
pubmed: 11042691
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
Sci Rep. 2017 Sep 6;7(1):10660
pubmed: 28878254
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Br J Dermatol. 2013 Dec;169(6):1279-87
pubmed: 23889214
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):139-44
pubmed: 19966280
PLoS One. 2012;7(1):e30377
pubmed: 22276185
Br J Dermatol. 2016 Feb;174(2):439-43
pubmed: 26211814
J Invest Dermatol. 2010 Jun;130(6):1537-42
pubmed: 20054342
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Br J Dermatol. 2013 May;168(5):1109-13
pubmed: 23278166
Genome Med. 2018 Apr 25;10(1):33
pubmed: 29695279
Nat Genet. 2019 Jan;51(1):36-41
pubmed: 30510240
Science. 2017 Mar 24;355(6331):1330-1334
pubmed: 28336671
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Cell. 2016 Jan 28;164(3):538-49
pubmed: 26806129
Hum Mutat. 2015 Apr;36(4):E2423-9
pubmed: 25703262
Nat Commun. 2016 Jan 11;7:10208
pubmed: 26751768
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Haematologica. 2020 Apr;105(4):e144-e146
pubmed: 31439674
J Med Genet. 2011 Mar;48(3):168-76
pubmed: 21097776
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Blood. 2019 Jun 20;133(25):2718-2724
pubmed: 30914417
Cancer Res. 2008 Mar 1;68(5):1347-53
pubmed: 18316597
Br J Dermatol. 1992 Nov;127(5):485-91
pubmed: 1281671
DNA Repair (Amst). 2013 Dec;12(12):1081-6
pubmed: 24084170
Genome Res. 2019 Jul;29(7):1067-1077
pubmed: 31221724
Environ Mol Mutagen. 2012 Dec;53(9):777-86
pubmed: 22965922

Auteurs

Andrey A Yurchenko (AA)

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

Ismael Padioleau (I)

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

Bakhyt T Matkarimov (BT)

National Laboratory Astana, Nazarbayev University, 010000, Astana, Kazakhstan.

Jean Soulier (J)

University of Paris, INSERM U944 and CNRS UMR7212, Institut de Recherche Saint-Louis, F-75010, Paris, France.

Alain Sarasin (A)

CNRS UMR9019 Genome Integrity and Cancers, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Sergey Nikolaev (S)

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France. sergey.nikolaev@gustaveroussy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH